☰

Ginelle C. Gellert, Ph.D. - Publications

Affiliations: 
2003 University of North Texas Health Science Center at Fort Worth 
Area:
Immunology, Cell Biology
Tree Info Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Yoon H, Kim DJ, Ahn EH, Gellert GC, Shay JW, Ahn CH, Lee YB. Antitumor activity of a novel antisense oligonucleotide against Akt1. Journal of Cellular Biochemistry. 108: 832-8. PMID 19693774 DOI: 10.1002/Jcb.22311  0.368
2006 Gellert GC, Dikmen ZG, Wright WE, Gryaznov S, Shay JW. Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer. Breast Cancer Research and Treatment. 96: 73-81. PMID 16319992 DOI: 10.1007/S10549-005-9043-5  0.331
2005 Herbert BS, Gellert GC, Hochreiter A, Pongracz K, Wright WE, Zielinska D, Chin AC, Harley CB, Shay JW, Gryaznov SM. Lipid modification of GRN163, an N3'-->P5' thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition. Oncogene. 24: 5262-8. PMID 15940257 DOI: 10.1038/Sj.Onc.1208760  0.342
2004 Gellert GC, Goldfarb RH, Kitson RP. Physical association of uPAR with the alphaV integrin on the surface of human NK cells. Biochemical and Biophysical Research Communications. 315: 1025-32. PMID 14985115 DOI: 10.1016/J.Bbrc.2004.01.163  0.449
2003 Gellert GC, Kitson RP, Goldfarb RH. Urokinase-type plasminogen activator receptor crosslinking in an NK cell line increases integrin surface expression by the MAP kinase/ERK 1/2 signaling pathway. Journal of Cellular Biochemistry. 89: 279-88. PMID 12704791 DOI: 10.1002/Jcb.10512  0.448
Show low-probability matches.